共 66 条
[1]
Hillemanns P(2013)Neue TNM-Klassifikation beim Endometriumkarzinom Best Practice Onkologie 8 22-27
[2]
Schmitt G(1994)The role of adjuvant treatment in endometrial cancer Strahlenther Onkol 170 561-564
[3]
Carl UM(2011)Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma Int J Radiat Oncol Biol Phys 81 e631-e638
[4]
Pape H(2004)A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma Gynecol Oncol 92 744-751
[5]
Creutzberg CL(1995)The value of a postoperative radiation therapy in FIGO stage I and II endometrial cancers Strahlenther Onkol 171 322-325
[6]
Nout RA(2005)Postoperative radiotherapy for Stage 1 endometrial carcinoma Int J Radiat Oncol Biol Phys 63 834-838
[7]
Lybeert MLM(2010)Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2) Lancet 375 816-823
[8]
Keys HM(2012)Current therapy of patients with endometrial carcinoma. A critical review Strahlenther Onkol 188 12-20
[9]
Roberts JA(2012)A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer Gynecol Oncol 127 351-355
[10]
Brunetto VL(2016)ESMO-ESGO-ESTRO consensus conference on endometrial cancer Ann Oncol 27 16-41